June 1, 2020 / 12:27 PM / a month ago

BRIEF-Delmar Pharmaceuticals To Present Updates Of Two Phase 2 Clinical Trials Of Val-083 At 2020 American Association For Cancer Research Virtual Annual Meeting Ii

June 1 (Reuters) - DelMar Pharmaceuticals Inc:

* DELMAR PHARMACEUTICALS TO PRESENT UPDATES OF TWO PHASE 2 CLINICAL TRIALS OF VAL-083 AT THE 2020 AMERICAN ASSOCIATION FOR CANCER RESEARCH VIRTUAL ANNUAL MEETING II Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below